×

Message

EU e-Privacy Directive

This website uses cookies to manage authentication, navigation, and other functions. By using our website, you agree that we can place these types of cookies on your device.

View e-Privacy Directive Documents

You have declined cookies. This decision can be reversed.

MOLECOLAR MYCOTHERAPY

Ganoderma Scientific Studies

Title
Probing Lingzhi or Reishi medicinal mushroom Ganoderma lucidum (higher Basidiomycetes): a bitter mushroom with amazing health benefits.
Anti-cancer properties of triterpenoids isolated from Ganoderma lucidum - a review.
Mycotherapy of cancer: an update on cytotoxic and antitumor activities of mushrooms, bioactive principles and molecular mechanisms of their action.
A Comprehensive Review of the Structure Elucidation and Biological Activity of Triterpenoids from Ganoderma spp.
Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients.
A Randomized, Placebo-Controlled, Multicenter Study of Ganoderma lucidum
Ganoderma lucidum ("Lingzhi"), a Chinese medicinal mushroom: biomarker responses in a controlled human supplementation study.
Ganoderma lucidum ('Lingzhi'); acute and short-term biomarker response to supplementation.
A phase I/II study of ling zhi mushroom ganoderma lucidum (W.Curt.: Fr.) LIoyd (Aphyllophoromycetideae) extract in patients with coronary heart disease
Monitoring of immune responses to a herbal immuno-modulator in patients with advanced colorectal cancer.

Page 1 of 2

Start
Prev
1
2
Next
End

Subcategories

Clinical Studies 15

REGISTERED: Handelsregister Schwyz

COMPANY NUMBER: CH-1029-379-06

TAX NUMBER: 1029-379-06

Copyright © 2017. All Rights Reserved.

Institute for Biomodulation Medicine AG

SCHWERZISTRASSE 4, CH-8807 FREIENBACH (SZ)
PHONE: +41 41 5003753 FAX: +41 41 5003754
EMAIL: INFO@BIOMODULATION.ORG

INSTITUTE FOR BIOMODULATION
MEDICINE

Today51

Yesterday411

This week1366

This month12097

Total965553

Thursday, 29 July 2021 03:12